Specialty: Primary Care, Primary sub-specialty: Public Health
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 65 years and over 2. With difficulty accessing the general practice 3. Two or more repeat prescriptions 4. Twelve or fewer nurse or GP consultations in the past 12 months (face-to-face, telephone or home visit) 5. No access to a car within their household 6. Living in a postcode in the highest Index of Multiple Deprivation quartile in the practice
Exclusion criteria
Exclusion criteria: 1. Significant cognitive impairment that would prevent them providing informed consent, such as dementia 2. Not able to speak English 3. Generally do not book their own appointments
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Pre-appointment transport options, ease of appointment and perceived convenience measured by a self-completed questionnaire designed for the purpose of this study at baseline, 6 months and each time appointment is booked 2. Post-appointment suitability of received appointment and transport to get to the appointment measured by a self-completed questionnaire designed for the purpose of this study at baseline, 6 months and each time appointment is booked | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Confidence and trust in GP practice measured by a self-completed questionnaire designed for the purpose of this study at baseline, 6 months and each time appointment is booked 2. Patient Activation Measure (PAM) measured by a self-completed questionnaire designed for the purpose of this study at baseline and 6 months 3. Quality of life (EQ5D and ICECAP-O) measured by a self-completed questionnaire designed for the purpose of this study at baseline and 6 months 4. Number and type of health professional contact measured by routine practice data for trial period from 6 months at baseline and follow-up 5. Hospital admissions measured by routine practice data for trial period from 6 months at baseline and follow-up 6. Intervention activity and process measures agreed by research team and practices measured by routine practice data for trial period from 6 months at follow-up 7. Number of referrals measured by routine practice data for trial period from 6 months at baseline and follow-up 8. Number of repeat medications measured by routine practice data for trial period from 6 months at baseline and follow-up | — |
Countries
United Kingdom